Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 438

1.

The Hippo-YAP pathway in organ size control and tumorigenesis: an updated version.

Zhao B, Li L, Lei Q, Guan KL.

Genes Dev. 2010 May;24(9):862-74. doi: 10.1101/gad.1909210.

2.

The Hippo-YAP pathway: new connections between regulation of organ size and cancer.

Zhao B, Lei QY, Guan KL.

Curr Opin Cell Biol. 2008 Dec;20(6):638-46. doi: 10.1016/j.ceb.2008.10.001. Epub 2008 Nov 18. Review.

3.

A role for Hipk in the Hippo pathway.

Heidary Arash E, Attisano L.

Sci Signal. 2013 May 14;6(275):pe18. doi: 10.1126/scisignal.2004259. Review.

PMID:
23674821
4.

Structural and functional insights into the TEAD-YAP complex in the Hippo signaling pathway.

Chen L, Loh PG, Song H.

Protein Cell. 2010 Dec;1(12):1073-83. doi: 10.1007/s13238-010-0138-3. Epub 2011 Jan 8.

5.

Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control.

Zhao B, Wei X, Li W, Udan RS, Yang Q, Kim J, Xie J, Ikenoue T, Yu J, Li L, Zheng P, Ye K, Chinnaiyan A, Halder G, Lai ZC, Guan KL.

Genes Dev. 2007 Nov 1;21(21):2747-61.

6.

The regulation and function of YAP transcription co-activator.

Zhu C, Li L, Zhao B.

Acta Biochim Biophys Sin (Shanghai). 2015 Jan;47(1):16-28. doi: 10.1093/abbs/gmu110. Epub 2014 Dec 8. Review.

PMID:
25487920
7.

E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components.

Kim NG, Koh E, Chen X, Gumbiner BM.

Proc Natl Acad Sci U S A. 2011 Jul 19;108(29):11930-5. doi: 10.1073/pnas.1103345108. Epub 2011 Jul 5.

8.

Disease implications of the Hippo/YAP pathway.

Plouffe SW, Hong AW, Guan KL.

Trends Mol Med. 2015 Apr;21(4):212-22. doi: 10.1016/j.molmed.2015.01.003. Epub 2015 Feb 18. Review.

9.

Snapshots of a hybrid transcription factor in the Hippo pathway.

Luo X.

Protein Cell. 2010 Sep;1(9):811-9. doi: 10.1007/s13238-010-0105-z. Epub 2010 Oct 7. Review.

10.
11.

Protein kinase A activates the Hippo pathway to modulate cell proliferation and differentiation.

Yu FX, Zhang Y, Park HW, Jewell JL, Chen Q, Deng Y, Pan D, Taylor SS, Lai ZC, Guan KL.

Genes Dev. 2013 Jun 1;27(11):1223-32. doi: 10.1101/gad.219402.113.

12.

Brahma regulates the Hippo pathway activity through forming complex with Yki-Sd and regulating the transcription of Crumbs.

Zhu Y, Li D, Wang Y, Pei C, Liu S, Zhang L, Yuan Z, Zhang P.

Cell Signal. 2015 Mar;27(3):606-13. doi: 10.1016/j.cellsig.2014.12.002. Epub 2014 Dec 8.

13.

Scaling the Drosophila Wing: TOR-Dependent Target Gene Access by the Hippo Pathway Transducer Yorkie.

Parker J, Struhl G.

PLoS Biol. 2015 Oct 16;13(10):e1002274. doi: 10.1371/journal.pbio.1002274. eCollection 2015 Oct.

14.

Elucidation of a universal size-control mechanism in Drosophila and mammals.

Dong J, Feldmann G, Huang J, Wu S, Zhang N, Comerford SA, Gayyed MF, Anders RA, Maitra A, Pan D.

Cell. 2007 Sep 21;130(6):1120-33.

15.

The Hippo signaling pathway in liver regeneration and tumorigenesis.

Hong L, Cai Y, Jiang M, Zhou D, Chen L.

Acta Biochim Biophys Sin (Shanghai). 2015 Jan;47(1):46-52. doi: 10.1093/abbs/gmu106. Epub 2014 Dec 4. Review.

PMID:
25476204
16.

Cysteine S-Glutathionylation Promotes Stability and Activation of the Hippo Downstream Effector Transcriptional Co-activator with PDZ-binding Motif (TAZ).

Gandhirajan RK, Jain M, Walla B, Johnsen M, Bartram MP, Huynh Anh M, Rinschen MM, Benzing T, Schermer B.

J Biol Chem. 2016 May 27;291(22):11596-607. doi: 10.1074/jbc.M115.712539. Epub 2016 Apr 5.

17.

Metabolic control of YAP and TAZ by the mevalonate pathway.

Sorrentino G, Ruggeri N, Specchia V, Cordenonsi M, Mano M, Dupont S, Manfrin A, Ingallina E, Sommaggio R, Piazza S, Rosato A, Piccolo S, Del Sal G.

Nat Cell Biol. 2014 Apr;16(4):357-66. doi: 10.1038/ncb2936. Epub 2014 Mar 23.

PMID:
24658687
18.

The Hippo size control pathway--ever expanding.

Lin JI, Poon CL, Harvey KF.

Sci Signal. 2013 Jan 22;6(259):pe4. doi: 10.1126/scisignal.2003813. Review.

PMID:
23354686
19.

YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway.

Zhang J, Ji JY, Yu M, Overholtzer M, Smolen GA, Wang R, Brugge JS, Dyson NJ, Haber DA.

Nat Cell Biol. 2009 Dec;11(12):1444-50. doi: 10.1038/ncb1993. Epub 2009 Nov 22.

20.

Mask is required for the activity of the Hippo pathway effector Yki/YAP.

Sansores-Garcia L, Atkins M, Moya IM, Shahmoradgoli M, Tao C, Mills GB, Halder G.

Curr Biol. 2013 Feb 4;23(3):229-35. doi: 10.1016/j.cub.2012.12.033. Epub 2013 Jan 17.

Supplemental Content

Support Center